PyInvesting

Market research

000908.SHE Hunan Jingfeng Pharmaceutical Co.,Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
11B
P/E ratio
Not available
Analyst target
12.5
Dividend yield
Not available
Beta
-0.15

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Hunan Jingfeng Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 4.3% below its 200 day moving average.

From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.

Hunan Jingfeng Pharmaceutical Co.,Ltd's total revenue rose by 8.1% to $372M since the same quarter in the previous year.

Its net income has increased by 69.5% to $-63M since the same quarter in the previous year.

Finally, its free cash flow grew by 30.7% to $-94M since the same quarter in the previous year.

Based on the above factors, Hunan Jingfeng Pharmaceutical Co.,Ltd gets an overall score of 4/5.